Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Keratin, Type II Cytoskeletal 8	NCIT_C126964	[Keratin, type II cytoskeletal 8 (483 aa, ~54 kDa) is encoded by the human KRT8 gene. This protein is involved in maintaining the structure of striated muscles and simple epithelia.]
MICA wt Allele	NCIT_C126960	[Human MICA wild-type allele is located in the vicinity of 6p21.3 and is approximately 16 kb in length. This allele, which encodes MHC class I polypeptide-related sequence A protein, is involved in natural killer cell inhibition. Variation of the gene may be associated with increased susceptibility to psoriasis 1 and psoriatic arthritis.]
Natural Killer Cell-Mediated Cytotoxicity Pathway	NCIT_C91442
MHC Class I Polypeptide-Related Sequence A	NCIT_C126961	[MHC class I polypeptide-related sequence A (383 aa, ~43 kDa) is encoded by the human MICA gene. This protein plays a role in the negative regulation of natural killer cells.]
Drug Development, Clinical	NCIT_C15800	[Drug development activites focused on clinical trials and testing.]
Drug Development, Preclinical	NCIT_C15801	[Drug development activites focused on preclinical trials and testing.]
Drug Discovery	NCIT_C15802
Drug Discovery Groups	NCIT_C15803	[Self-identified projects in the Biochemistry and Pharmacology Cancer Activity.]
EPS Library	NCIT_C15804	[Library located at Executive Plaza South.]
Experimental Nutrition	NCIT_C15805
Health and Behavior in Children	NCIT_C15806
Child Health Study	NCIT_C15203
High Dose Chemotherapy	NCIT_C15807	[A cancer treatment having a treatment dose that is higher than the standard dosage levels recommended on the product labeling for that chemotherapeutic agent. This dose is concurrently toxic and destroys the normal bone marrow stem cells.]
Intercept Vertical Transmission-Perinatal Transmission of HIV	NCIT_C15808	[Develop, evaluate, and implement strategies for interrupting vertical transmission of HIV from mother to child and extend our understanding of perinatal transmission and the pathogenesis of early infection (treatment of children will be addressed in other objectives). (Note: The OAR Coordinating Committee on Therapeutics feels scientific objectives 3E through 3G are of equal weight in terms of scientific priorities.)]
Laboratory Animal Production and Facilities	NCIT_C15809	[The production of laboratory animals for research.]
Core Facility	NCIT_C15896	[Shared facilities which provide services of a particular area of expertise.]
Laboratory/Correlate Data	NCIT_C15810
Low Dose Radiation Therapy	NCIT_C15811	[Radiotherapy using radioactive particles that deposit a low amount of energy by radiation per unit length of travel.]
Maternal and Child Health Study	NCIT_C15812	[Studies focusing on the involvement of maternal factors (and efforts to modify these factors) that may affect the health of the child or fetus: smoking or exposure to drugs or toxic chemicals during pregnancy, maternal/fetal immunologic interactions.]
Population Research	NCIT_C15878	[Research on fertility, contraceptives, transplacental carcinogenesis or other in utero or pre-conception disease induction.]